VCYT FY 2022 Earnings — Veracyte, Inc. Revenue & Financial Results | Market Cap Arena

VCYTVeracyte, Inc.

$3B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$297M+35.1% YoY

Gross Profit

$195M65.7% margin

Operating Income

-$41M-13.9% margin

Net Income

-$37M-12.3% margin

EPS (Diluted)

$-0.51

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

-$1M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$81M

Stockholders' Equity

$1.1B

Cash & Equivalents

$154M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$297M	$220M	+35.1%
Gross Profit	$195M	$145M	+34.3%
Operating Income	-$41M	-$82M	+49.8%
Net Income	-$37M	-$76M	+51.6%